引用本文:衷 昕,刘矫连,梁永顺,杨 勇.单一注射器气液交换法治疗增生性糖尿病视网膜病变玻璃体切除术后玻璃体再出血的疗效观察[J].中国临床新医学,2021,14(8):799-801.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1758次   下载 1368 本文二维码信息
码上扫一扫!
分享到: 微信 更多
单一注射器气液交换法治疗增生性糖尿病视网膜病变玻璃体切除术后玻璃体再出血的疗效观察
衷 昕,刘矫连,梁永顺,杨 勇
530021 南宁,广西医科大学第一附属医院眼科
摘要:
[摘要] 目的 观察单一注射器气液交换法治疗增生性糖尿病视网膜病变玻璃体切除术后玻璃体再出血的疗效。方法 选择2019年1月至2020年12月广西医科大学第一附属医院收治的30例增生性糖尿病视网膜病变行玻璃体切除术后再出血患者的临床资料。患者均取坐位或俯卧位,以单一注射器行玻璃体腔气液交换术治疗。观察患者术后视力、晶状体、眼底和眼压等情况。结果 2例(6.67%)因术后第2次出血需再次行玻璃体腔气液交换术。患者术后视力均明显改善,与术前比较差异有统计学意义[(0.60±0.34)logMAR(术后) vs (1.47±0.52)logMAR(术前);t=8.267,P=0.001]。30例患者术后14 d均可以清楚观察眼底,眼压均在正常范围,其中气体吸收后仍需使用降眼压药者2例。结论 应用单一注射器行玻璃体腔气液交换术治疗增生性糖尿病视网膜病变玻璃体切除术后玻璃体再出血安全、有效。
关键词:  糖尿病视网膜病变  玻璃体切除术  再出血  单一注射器  气液交换术
DOI:10.3969/j.issn.1674-3806.2021.08.14
分类号:R 776.4
基金项目:广西卫健委科研课题(编号:Z20180967)
Observation on the effect of single syringe gas-liquid exchange on treatment of vitreous rebleeding after vitrectomy for proliferative diabetic retinopathy
ZHONG Xin, LIU Jiao-lian, LIANG Yong-shun, et al.
Department of Ophthalmology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China
Abstract:
[Abstract] Objective To observe the effect of single syringe gas-liquid exchange on treatment of vitreous rebleeding after vitrectomy for proliferative diabetic retinopathy. Methods The clinical data of 30 patients suffering from vitreous rebleeding after vitrectomy for proliferative diabetic retinopathy and admitted to the First Affiliated Hospital of Guangxi Medical University from January 2019 to December 2020 were selected. All the patients were in sitting or prone position, and the vitreous cavity gas-liquid exchange surgery was performed using a single syringe. The patients′ the postoperative visual acuity, lens, fundi and intraocular pressure were observed. Results Of the 30 patients, 2 patients(6.67%) needed to receive vitreous gas-liquid exchange surgery again due to the second postoperative bleeding. Compared with that before surgery, the visual acuity of the 30 patients improved significantly after surgery, and the difference was statistically significant[(0.60±0.34)logMAR(postoperative) vs (1.47±0.52)logMAR(preoperative); t=8.267, P=0.001]. The fundi of the 30 patients could be observed clearly 14 days after surgery, and the intraocular pressure was in the normal range. Among them, 2 patients still needed to use ocular hypotensive agents after gas absorption. Conclusion It is safe and effective to use a single syringe to perform vitreous cavity gas-liquid exchange surgery on patients suffering from vitreous rebleeding after vitrectomy for proliferative diabetic retinopathy.
Key words:  Diabetic retinopathy  Vitrectomy  Rebleeding  Single syringe  Gas-liquid exchange